Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia

Emilie Kristine Dahl; L L Gluud; N Kimer; A Krag

doi:10.1111/apt.12025

Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia

Emilie Kristine Dahl, L L Gluud, N Kimer, A Krag

80 Citationer (Scopus)

Abstract

Vaptans may correct hyponatraemia and mobilise ascites through an increased excretion of water. The effect on clinical outcomes is debated.

Originalsprog	Engelsk
Tidsskrift	Alimentary Pharmacology and Therapeutics
Vol/bind	36
Udgave nummer	7
Sider (fra-til)	619-26
Antal sider	8
ISSN	0269-2813
DOI	https://doi.org/10.1111/apt.12025
Status	Udgivet - 2012

Adgang til dokumentet

10.1111/apt.12025

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{f13cbcd82cc44754a15a66caf064ddbd,

title = "Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia",

abstract = "Vaptans may correct hyponatraemia and mobilise ascites through an increased excretion of water. The effect on clinical outcomes is debated.",

author = "Dahl, \{Emilie Kristine\} and Gluud, \{L L\} and N Kimer and A Krag",

note = "{\textcopyright} 2012 Blackwell Publishing Ltd.",

year = "2012",

doi = "10.1111/apt.12025",

language = "English",

volume = "36",

pages = "619--26",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "John Wiley and Sons Inc.",

number = "7",

}

TY - JOUR

T1 - Meta-analysis

T2 - the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia

AU - Dahl, Emilie Kristine

AU - Gluud, L L

AU - Kimer, N

AU - Krag, A

PY - 2012

Y1 - 2012

N2 - Vaptans may correct hyponatraemia and mobilise ascites through an increased excretion of water. The effect on clinical outcomes is debated.

AB - Vaptans may correct hyponatraemia and mobilise ascites through an increased excretion of water. The effect on clinical outcomes is debated.

UR - https://www.scopus.com/pages/publications/84866245430

U2 - 10.1111/apt.12025

DO - 10.1111/apt.12025

M3 - Journal article

C2 - 22908905

SN - 0269-2813

VL - 36

SP - 619

EP - 626

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 7

ER -

Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater